Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.
Journal: Bone marrow transplantation
Published: November 07, 2025
On the Road to Safer CAR Therapy for B-Cell Lymphoma: Real-World Evidence.
Journal: Transplantation and cellular therapy
Published: July 05, 2025
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma.
Journal: Cancer cell
Published: October 31, 2024
PARP1 promotes tumor proliferation in lenalidomide-resistant multiple myeloma via the downregulation of microRNA-192-5p-AKT signaling.
Journal: Translational cancer research
Published: August 28, 2024
Mapping the cancer surface proteome in search of target antigens for immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 01, 2024
Shifting gears with CAR T cells for autoimmune diseases.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 10, 2024
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Journal: Frontiers in immunology
Published: September 28, 2018
Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: March 10, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026